Advanced Ovarian Cancer and Paclitaxel

Links shared publicly online about this topic

Predicting Cellular Response To Paclitaxel In Epithelial Ovarian Cancer

medicalnewstoday.com — “New research findings by UCD scientists published online today in the Journal of Pathology may help clinicians predict how patients with high grade, serous, epithelial ovarian cancer will respondView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on November 12, 2011 at 8:05 am By:

mnt_ovariancanc MNT Ovarian Cancer Health News

Predicting Cellular Response To Paclitaxel In Epithelial Ovarian Cancer http://t.co/X7z0k7d9 #ovariancancer

6 months ago...

Predicting cellular response to paclitaxel in epithelial ovarian cancer

medicalxpress.com — “(Medical Xpress) -- New research findings by UCD scientists published online in the Journal of Pathology may help clinicians predict how patients with high grade, serous, epithelial ovarian cancer will respond to paclitaxel chemotherapy (Taxol).View full resource at medicalxpress.com

  • View Related
  • Share

Most Recently Shared on November 16, 2011 at 4:09 pm By:

OvarianCancer_ Ovarian Cancer OW OW Health

Predicting cellular response to paclitaxel in epithelial ovarian cancer: (Medical Xpress) -- New research findin... http://t.co/Wd8cS7gk

6 months ago...

Oncology Article | Carboplatin Ovarian Neoplasms Paclitaxel

mdlinx.com — “Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancerView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on January 31, 2011 at 6:17 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-r... http://bit.ly/eDTbxA #oncology

1 year ago...

Oncology Article | Carboplatin Ovarian Neoplasms Paclitaxel

mdlinx.com — “Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/ refractory epithelial ovarian cancerView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on July 13, 2011 at 7:49 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery o... http://bit.ly/qLdG64 #oncology

10 months ago...

Treatment for Advanced Ovarian Cancer Effective

disabled-world.com — “New treatment regimen shown effective against advanced ovarian cancerView full resource at disabled-world.com

  • View Related
  • Share

Most Recently Shared on June 6, 2010 at 11:31 pm By:

Ovarian Cancer

springer.com — “Ovarian carcinoma continues to be responsible for more deaths than all other gynecologic malignancies combined, due to a continued inability to achieve detection of early (rather than advanced) stage disease and the lack of ...View full resource at springer.com

  • View Related
  • Share

Most Recently Shared on March 16, 2012 at 6:27 pm By:

OvarianCancer_ Ovarian Cancer OW OW Health

Ovarian Cancer: Second Editionseries:Cancer Treatment and ResearchOvarian carcinoma continues to be responsible ... http://t.co/GanmC9SK

2 months ago...

For The Treatment Of Ovarian Cancer, Pegylated Liposomal Doxorubicin/Carboplatin Will Replace Paclitaxel/Carboplatin

medicalnewstoday.com — “Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although platinum-based treatment will continue to be the standard oView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on December 9, 2010 at 3:37 pm By:

medical_tweets medical_tweets Health News

For The Treatment Of Ovarian Cancer, Pegylated Liposomal Doxorubicin/Carboplatin Will Replace Paclitaxel/Carboplatin De.. http://dld.bz/AcP7

1 year ago...

Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial : The Lancet

thelancet.com — “Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial. By - Prof Elisabe...View full resource at thelancet.com

  • View Related
  • Share

Most Recently Shared on August 9, 2011 at 2:37 pm By:

TheLancet The Lancet Medical Journal

Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study http://t.co/GGUhJbj

10 months ago...

Ovarian cancer advances when genes are silenced

eurekalert.org — “Researchers at the Duke Cancer Institute have found evidence of epigenetics at work on a genome-wide scale in cases of ovarian cancer. One major biological signaling pathway in particular was found to contain many genes influenced by DNA methylation -- a mechanism for turning off genes -- in tumor cells.View full resource at eurekalert.org

  • View Related
  • Share

Most Recently Shared on December 14, 2010 at 4:41 pm By:

twitterbo Bo Health Site

Ovarian cancer advances when genes are silenced ---> http://dld.bz/ANpD

1 year ago...

Ovarian cancer advances when genes are silenced

labspaces.net — “There are many mechanisms that alter the activity of genes -- direct changes to the DNA code like mutations and deletions, or changes that control when genes are switched on and off, called epigenetic means. Tumor-suppressor genes are often inactivated through epigenetics, which provides an opening for the cancerous growth of cells.View full resource at labspaces.net

  • View Related
  • Share

Most Recently Shared on December 14, 2010 at 4:48 pm By:

LabSpaces Brian Krueger Health News

Ovarian cancer advances when genes are silenced - http://is.gd/iJVou

1 year ago...

Key advances in ovarian cancer (ASCO 2010 ) Video

vodpod.com — “Prof Jonathan Ledermann outlines some of the key advances in ovarian cancer that have been presented at ASCO 2010. Prof Ledermann discusses research demonstrating the effectiveness of combining bevacizumab with chemotherapy as first line treatment of ovarian cancer. A second key presentation was research indicating that PARP inhibitors are effective at treating not just ovarian cancer caused by BRCA mutation but also high grade serous cancer. If this result is confirmed in further studies, it woView full resource at vodpod.com

  • View Related
  • Share

Most Recently Shared on July 22, 2010 at 9:59 pm By:

libbyshope Paul Cacciatore Patient Advocate

Prof Jonathan Ledermann outlines some of the key advances in ovarian cancer that have been presented at ASCO 2010. Pro… http://bit.ly/b7acun

2 years ago...

Ovarian cancer advances when genes are silenced

sciencedaily.com — “Researchers have found evidence of epigenetics at work on a genome-wide scale in cases of ovarian cancer. One major biological signaling pathway in particular was found to contain many genes influenced by DNA methylation -- a mechanism for turning off genes -- in tumor cells.View full resource at sciencedaily.com

  • View Related
  • Share

Most Recently Shared on December 14, 2010 at 3:38 am By:

OvarianCancer_ Ovarian Cancer OW OW Health

Ovarian cancer advances when genes are silenced: Researchers have found evidence of epigenetics at work on a gen... http://bit.ly/hM8eZ9

1 year ago...

7 Clues to Ovarian Cancer

webmd.com — “Seven symptoms often reported to doctors are associated with ovarian cancer, according to a new study from the U.K., dispelling the idea that the deadly cancer is a ''silent killer'' with few clues until the advanced stages.View full resource at webmd.com

  • View Related
  • Share

Most Recently Shared on August 25, 2009 at 11:47 pm By:

WebMD_News WebMD_News Health News

7 Clues to Ovarian Cancer: Seven symptoms often reported to doctors are associated with ovarian cancer, accordin.. http://bit.ly/17OJmo

3 years ago...

Ovarian Cancer Genes Found

webmd.com — “A newly identified group of genes may play a role in ovarian cancer risk, a study shows.View full resource at webmd.com

  • View Related
  • Share

Most Recently Shared on September 20, 2010 at 5:06 pm By:

WebMD_News WebMD_News Health News

Ovarian Cancer Genes Found: A newly identified group of genes may play a role in ovarian cancer risk, a study shows. http://bit.ly/d0fl6C

2 years ago...

Ovarian Cancer Genes Found

webmd.com — “A newly identified group of genes may play a role in ovarian cancer risk, a study shows.View full resource at webmd.com

  • View Related
  • Share

Most Recently Shared on September 20, 2010 at 8:13 pm By:

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

  • mnt_ovariancanc

    MNT Ovarian Cancer

    The latest ovarian cancer news published daily. Articles from research centers, universities and prestigious journals.

    View Profile

  • OvarianCancer_

    Ovarian Cancer OW

    Organizing ovarian cancer resources shared by health experts, advocates, and organizations into WisdomCards.

    View Profile

  • MDLinx

    Sandeep Pulim MD

    Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390